Inhibition of Yarrowia lipolytica 24-SMT assessed as zymosterol-3-trimethylsilyl derivative level at 2 ug/mL after 48 hrs by GC-MS analysis relative to untreated control
Inhibition of Yarrowia lipolytica 24-SMT assessed as zymosterol-3-trimethylsilyl derivative level at 0.1 ug/mL after 48 hrs by GC-MS analysis relative to untreated control
Inhibition of Yarrowia lipolytica 24-SMT assessed as zymosterol-3-trimethylsilyl derivative level at 0.06 ug/mL after 48 hrs by GC-MS analysis relative to untreated control
Inhibition of Yarrowia lipolytica 24-SMT assessed as zymosterol-3-trimethylsilyl derivative level at 0.2 ug/mL after 48 hrs by GC-MS analysis relative to untreated control
Inhibition of Yarrowia lipolytica 24-SMT assessed as ergosterol-3-trimethylsilyl derivative level at 0.2 ug/mL after 48 hrs by GC-MS analysis relative to untreated control
Inhibition of Yarrowia lipolytica 24-sterol C-methyltransferase assessed as ergosterol-3-trimethylsilyl derivative level at 2 ug/mL after 48 hrs by GC-MS analysis relative to untreated control
Inhibition of Yarrowia lipolytica 24-sterol C-methyltransferase assessed as ergosterol-3-trimethylsilyl derivative level at 1 ug/mL after 48 hrs by GC-MS analysis relative to untreated control
Inhibition of Yarrowia lipolytica 24-sterol C-methyltransferase assessed as ergosterol-3-trimethylsilyl derivative level at 0.06 ug/mL after 48 hrs by GC-MS analysis relative to untreated control
Inhibition of Yarrowia lipolytica 24-sterol C-methyltransferase assessed as cholesta-5,7,24-trien-3-trimethylsilyl derivative at 1 ug/mL after 48 hrs by GC-MS analysis relative to untreated control
Inhibition of Yarrowia lipolytica 24-SMT assessed as cholesta-5,7,24-trien-3-trimethylsilyl derivative at 2 ug/mL after 48 hrs by GC-MS analysis relative to untreated control
Inhibition of Yarrowia lipolytica 24-SMT assessed as cholesta-5,7,24-trien-3-trimethylsilyl derivative at 8 ug/mL after 48 hrs by GC-MS analysis relative to untreated control
Inhibition of Yarrowia lipolytica 24-SMT assessed as cholesta-5,7,24-trien-3-trimethylsilyl derivative at 0.2 ug/mL after 48 hrs by GC-MS analysis relative to untreated control
Inhibition of Yarrowia lipolytica 24-SMT assessed as cholesta-5,7,24-trien-3-trimethylsilyl derivative at 0.1 ug/mL after 48 hrs by GC-MS analysis relative to untreated control
Inhibition of Yarrowia lipolytica 24-SMT assessed as cholesta-5,7,24-trien-3-trimethylsilyl derivative at 0.06 ug/mL after 48 hrs by GC-MS analysis relative to untreated control
Inhibition of Yarrowia lipolytica 24-SMT assessed as cholesta-7,24-dien-3-trimethylsilyl derivative at 1 ug/mL after 48 hrs by GC-MS analysis relative to untreated control
Inhibition of Yarrowia lipolytica 24-SMT assessed as cholesta-7,24-dien-3-trimethylsilyl derivative at 2 ug/mL after 48 hrs by GC-MS analysis relative to untreated control
Inhibition of Yarrowia lipolytica 24-SMT assessed as cholesta-7,24-dien-3-trimethylsilyl derivative at 8 ug/mL after 48 hrs by GC-MS analysis relative to untreated control
Inhibition of Yarrowia lipolytica 24-SMT assessed as cholesta-7,24-dien-3-trimethylsilyl derivative at 0.2 ug/mL after 48 hrs by GC-MS analysis relative to untreated control
Inhibition of Yarrowia lipolytica 24-SMT assessed as cholesta-7,24-dien-3-trimethylsilyl derivative at 0.06 ug/mL after 48 hrs by GC-MS analysis relative to untreated control
Inhibition of Yarrowia lipolytica 24-SMT assessed as cholesta-7,24-dien-3-trimethylsilyl derivative at 0.1 ug/mL after 48 hrs by GC-MS analysis relative to untreated control